The Street Might Be Discounting A Potential Blockbuster Drug From Acceleron By: Benzinga via Benzinga January 21, 2016 at 07:35 AM EST Acceleron Pharma Inc (NASDAQ: XLRN) shares have plunged 23 percent since December 21. Credit Suisse’s Kennen MacKay ... Read More >> Related Stocks: Acceleron Pharma